The neuroprotective role is confirmed by some researchers, such as H. Tokami et al. [22] observed an increased plasma RANTES concentration in patients with ischemic stroke on day 0 from the onset of infarction symptoms. This evidence concerns the gene CCL5 and ischemic stroke.